Golnaz Morad: Bringing the Next Wave of Cancer Immunotherapy to SITC 2026
Golnaz Morad/LinkedIn

Golnaz Morad: Bringing the Next Wave of Cancer Immunotherapy to SITC 2026

Golnaz Morad, Assistant Member/Professor at Moffitt Cancer Center and Principal Investigator of the Morad Lab, shared on LinkedIn:

“Excited to be presenting at the Society for Immunotherapy of Cancer (SITC) 41st Annual Meeting (SITC 2026)!

Looking forward to reconnecting with friends and colleagues for a week of groundbreaking science and great networking.

As a member of SITC’s Early Career Scientist Committee, I’m also especially looking forward to the events we’ve been planning for early-career investigators this year.

If you haven’t had a chance to register, click here: ”

Golnaz Morad: Bringing the Next Wave of Cancer Immunotherapy to SITC 2026